Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FZ1KS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,398
Award facts
- Contract value 100% obligated
- $13,397.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,397.76 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/mL SureClick auto-injector medication. This firm fixed-price, non-set-aside contract was awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp fulfills this delivery order under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical supply needs across the U.S. military healthcare system globally.
This delivery order represents a routine transactional award within AmerisourceBergen Drug Corp's extensive federal pharmaceutical distribution portfolio, which includes brand-name and generic medications, vaccines, and specialized medical supplies serving Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Enbrel, a TNF inhibitor commonly used for rheumatoid arthritis and other autoimmune conditions, reflects the company's ongoing role in providing specialized therapeutic medications to support military medical readiness. The award demonstrates the contractor's continued capability to meet federal procurement requirements through competitive open-market contracting.
Quick answers
Who was awarded contract SPE2DB25FZ1KS?
SPE2DB25FZ1KS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FZ1KS worth?
The government has obligated $13,398 on SPE2DB25FZ1KS.
Is contract SPE2DB25FZ1KS an order under another contract?
Yes. SPE2DB25FZ1KS is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB25FZ1KS competed?
The extent of competition for SPE2DB25FZ1KS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award